Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Hospitals squeezed by high drug costs

Stock MarketsJan 16, 2019 12:20PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. Hospitals squeezed by high drug costs
  • A study funded by the American Hospital Association, Federation of American Hospitals and the American Society of Health-System Pharmacists found that total drug spend per hospital admission rose 18.5% between 2015 and 2017, adding $1.8M in additional costs for an average hospital.
  • Outpatient drug spending per admission rose almost 30% while inpatient spending for medicines rose 10%. Price hikes as high as 80% or more occurred in anesthetics, parenteral solutions, opioid agonists and chemo.
  • More than 90% of hospitals surveyed had to identify alternative therapies to mitigate the impact of price increases and drug shortages. One in four had to downsize staff.
  • The price of Roche's stroke med Activase increased 19% to $4,143. Johnson & Johnson's Remicade, AbbVie's Humira and Amgen's Enbrel increased between 15 - 21%.
  • The majority of hospitals reported that competition had little effect on prices. Two of the 10 most expensive drugs in fiscal 2017 had generic or biosimilar alternatives enter the market in 2016, but the two still increased 4.1%, albeit more modestly than the 14.4% average hike among the other eight.
  • About 750 hospitals have joined a non-profit venture called Civica Rx aimed at managing drug costs and supply.

  • Now read: Bristol-Myers Squibb Stock Issued For Celgene: I Plan To Keep It

Original article
Hospitals squeezed by high drug costs

Related Articles

Europe needs long-term energy plan, Eni CEO says
Europe needs long-term energy plan, Eni CEO says By Reuters - Sep 25, 2021 2

MILAN (Reuters) - Soaring gas prices as winter approaches are evidence that the European Union needs to work out a long-term energy security plan, the head of Italy's Eni has told...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email